Spironolactone for PCOS: Hirsutism, Acne, Hair Loss & What to Expect on Treatment
Spironolactone treats PCOS hirsutism, acne & androgen hair loss by blocking testosterone at the source. 2026 guide: dosing, side effects, timeline & who benefits.
In a nutshell
Spironolactone in 60 seconds — Spironolactone is a 60-year-old blood-pressure pill that blocks androgens at the hair follicle, oil gland, and scalp. In women with PCOS, it reduces facial and body hair (hirsutism), clears androgen-driven acne, and slows scalp thinning. Typical dose: 50–200 mg/day. First visible results: 3–6 months. Side effects are usually mild and dose-dependent. Birth control is required if you can become pregnant.
(Render as a pink-banner callout immediately under the H1. This block is built to be harvested by Google’s AI Overview and to answer the dominant PAA strings in a single scroll.)
1. The 30-second version of how it works
Spironolactone (brand names Aldactone, CaroSpir) is a potassium-sparing diuretic — meaning a blood pressure pill — that turned out, almost by accident, to be one of the most effective anti-androgens we have. The reason it works for PCOS isn’t that it touches your ovaries. It works in two specific places:
- At the hair follicle and oil gland, it blocks the androgen receptor so that testosterone and DHT can’t dock and trigger coarse hair growth or oil overproduction.
- In the adrenal cortex and ovary, it modestly suppresses the enzymes (17α-hydroxylase, 17,20-lyase) that build testosterone from cholesterol — so circulating androgen levels also drop a little.[1]
That’s it. It is not a hormone replacement. It does not “balance” your hormones in any vague sense. It is a receptor blocker with a known mechanism and 60 years of clinical data behind it.
The thing it does not do — and this is where most reader confusion lives — is fix the upstream PCOS engine. If insulin resistance is driving your ovaries to overproduce androgens, spironolactone is treating the symptom. The medication that addresses the engine itself is metformin, or in 2026, a GLP-1 receptor agonist. The two strategies are not in competition. They do different jobs and are often used together.
2. Who actually benefits from spironolactone — the 4-PCOS-types lens
Reproductive endocrinology has, for over a decade, recognized that “PCOS” is really four overlapping presentations driven by different mechanisms. Spironolactone is helpful for all four, but the role it plays — first-line, add-on, or last resort — depends on your type. This matters because the wrong starting drug delays results by 6-12 months.
| PCOS subtype | Primary driver | Where spironolactone fits | What to try first |
|---|---|---|---|
| Insulin-resistant PCOS (most common) | High insulin → ovarian overproduction of testosterone | Add-on, not first-line. Insulin sensitization (lifestyle + metformin/GLP-1) often reduces androgens enough on its own. Spiro layered on if hirsutism/acne persists at 6 months. | Lifestyle (CGM-guided diet, walking after meals) → metformin → spironolactone |
| Adrenal PCOS | Elevated DHEA-S (adrenal androgens), often normal ovarian function | First-line for symptoms. Insulin is rarely the issue, so insulin sensitizers don’t help. Spironolactone directly blocks the androgen action. | Spironolactone ± cortisol/sleep work |
| Post-pill PCOS | Transient androgen rebound after stopping hormonal contraceptives | Short-term bridge. Symptoms often resolve in 6-12 months on their own. Spiro can smooth the rebound period if visible symptoms are severe. | Wait + lifestyle; spiro if symptoms warrant it |
| Inflammatory PCOS | Chronic low-grade inflammation amplifying androgen sensitivity at the follicle | Add-on after addressing inflammation. Skin-level androgen sensitivity is high here, so spiro works well, but missing the inflammation root means symptoms return when you stop. | Anti-inflammatory diet + gut work → spiro for residual symptoms |
If you’re not sure which subtype you fit, the PCOS-types quiz maps your specific lab and symptom pattern to one of these four — and to the treatment ladder that matches.
In our coaching cohort, women with insulin-resistant PCOS who start spironolactone before addressing insulin frequently report that “the hair stopped growing but I still feel terrible.” That’s the missed-engine problem. The cleaner sequence — insulin-first, spiro-second — also tends to produce better skin and energy outcomes because you’re treating the cause, not just the cosmetic surface.
3. What spironolactone actually treats in PCOS
The drug is FDA-approved for hypertension, heart failure, and certain forms of edema. Everything below is technically off-label for women with PCOS, but is supported by decades of clinical practice and a meaningful base of randomized evidence.
3a. Hirsutism (unwanted facial and body hair)
This is the best-studied use. A 2026 systematic review and meta-analysis in Clinical Endocrinology pooled 5 randomized controlled trials of short-term, low-dose spironolactone in PCOS hyperandrogenic symptoms and found a meaningful reduction in modified Ferriman-Gallwey hirsutism scores compared to placebo or alternative anti-androgens.[2] A broader review of 24 RCTs found spironolactone 100 mg/day reduced FG score more than finasteride or cyproterone acetate in idiopathic hirsutism.[3]
Translation: spironolactone works as well as or better than the comparator anti-androgens, with a longer real-world safety record and lower cost. For most women on 100-200 mg/day, by month 6 the hair is thinner, slower-growing, and lighter; by month 12, many find they need to shave or wax less often. Spironolactone won’t remove existing terminal hairs that are already established — that requires laser or electrolysis — but it stops new ones from being recruited and shrinks the ones already in growth phase.
3b. Acne (especially jawline, chin, lower-face)
Spironolactone went from “off-label option” to “evidence-based first-line for adult female acne” in 2023 with the SAFA trial — a UK multicenter, double-blind, placebo-controlled RCT of 410 women published in The BMJ and Health Technology Assessment. At 24 weeks, Acne-QoL symptom scores improved 21.2 vs 17.4 placebo (adjusted difference 3.45); use of oral antibiotics at 52 weeks dropped 5.8% vs 13.5% in placebo.[4][5] This is the first large, modern, placebo-controlled trial confirming what dermatologists have observed for years: spironolactone clears hormonal acne in adult women, and it does so without putting them on six months of doxycycline.
For PCOS acne specifically — that deep, cystic pattern along the jawline, chin, and neck that flares the week before your period — spiro works because that exact distribution is androgen-driven. If your acne is also on your chest and back, that’s a strong PCOS-androgen pattern too. Topical retinoids stay valuable here, but spiro is what addresses the cause. Aspect’s PCOS acne deep-dive has the full skincare layer.
3c. Androgen-driven scalp hair loss (female-pattern thinning)
This is the third androgen-target, and the one most readers don’t realize spironolactone treats. PCOS-related thinning shows up as a widening of the part line at the crown, with the frontal hairline preserved. It’s driven by the same androgen activity that’s making facial hair coarser — the follicles on top of your head are receptor-sensitive to DHT in a way that’s the opposite of facial follicles.
Spironolactone at 100-200 mg/day, given long enough (12+ months is the realistic timeframe), modestly slows progression and produces visible regrowth in a subset of women — but it’s not the dramatic facial-hair-and-acne win. Combination with topical minoxidil 5% improves the response. Aspect’s PCOS hair loss treatment guide covers the full protocol.
Not sure if spironolactone is the right move for your PCOS?
Take the free Aspect Health PCOS quiz — get your subtype, the medication ladder that fits it, and a clear next step to discuss with your clinician.
Take the PCOS Quiz →4. Dosing — the actual protocol clinicians use
The label dose (for hypertension) is 25-200 mg/day. For PCOS/dermatologic use, the practical range is 50-200 mg/day, with most women landing at 100 mg/day as a steady-state dose. Here’s how it typically gets prescribed:
- Start low, titrate. A common starting dose is 50 mg once daily for 4-6 weeks. This is the SAFA trial protocol, the Endocrine Society’s recommendation, and a sensible starting point — it lets the body adapt to the diuretic effect (and the inevitable extra bathroom trips) before pushing the dose up.[4][6]
- Move to 100 mg/day at week 6. If tolerated, this is the standard maintenance dose for most women. Often split into 50 mg twice daily (some clinicians prefer once daily; both work).
- Up to 200 mg/day if needed. For more severe hirsutism — especially if combined with idiopathic hirsutism or strong family history — clinicians may go to 150-200 mg/day. Evidence supports the 100-200 mg/day range as the effective window.[7]
- Long-term maximum: 400 mg/day per UK NHS prescribing guidance. This is rarely used for PCOS — it’s a dose more commonly seen in heart failure or refractory edema.[8]
- Best taken with food to reduce nausea, and not at bedtime (the diuretic effect will wake you up).
- Re-evaluation at 6 and 12 months. Many women stay on spironolactone for years if it’s working and well-tolerated. There’s no built-in stop point.
5. A month-by-month timeline — what’s actually happening
Most patients (and many doctors) underweight how long the response takes. Hair follicles cycle every 3-4 months. Your skin replaces its surface layer every 4-6 weeks. The visible result of a follicle-level intervention is therefore months away. Here’s what to genuinely expect, based on the trial timelines:
| Month | What’s measurable | What you’ll feel |
|---|---|---|
| Month 1 | Diuretic effect kicks in within days. Serum androgens drop within 2-4 weeks.[1] | More frequent urination. Maybe slight breast tenderness (it usually settles). Skin may flare briefly before it clears. |
| Month 3 | Acne starts to improve. SAFA showed a measurable Acne-QoL benefit at week 12.[4] | Fewer new pimples along the jawline. Existing hair growth hasn’t visibly slowed yet — too early. |
| Month 6 | Hirsutism improvement is now visible. Most patients report measurably less facial-hair density. Scalp shedding may begin to slow. | You’re shaving or waxing less often. Skin is clearer. |
| Month 12 | Maximum hirsutism benefit typically reached. Scalp hair: stable shedding, modest regrowth in some. | The peak result. Hair-removal frequency may drop 50% or more. |
| Months 12+ | Maintenance. Stopping causes androgens to rise back to baseline within 3-6 months and symptoms return. | Most women stay on the drug long-term if it’s working and well-tolerated. |
If after 6 months on a stable 100-200 mg/day dose you’ve seen no meaningful change in hirsutism or acne, that’s the point to revisit the diagnosis. Either the symptoms aren’t primarily androgen-driven (e.g., insulin resistance is overshadowing them), or another driver — thyroid, congenital adrenal hyperplasia, hyperprolactinemia — is in the mix.
6. The 2026 safety story (better than you’ve heard)
The single biggest reason women hesitate to start spironolactone is fear of “high potassium.” That fear is mostly outdated.
The Plovanich data (2015, replicated since). A retrospective study of 974 otherwise healthy women on spironolactone for acne, age 18-45, found a hyperkalemia rate of 0.72% — identical to the 0.76% rate in matched women not on the drug. The conclusion: routine potassium monitoring in healthy young women on spironolactone is low-yield.[9] This finding has been repeated in multiple 2023-2024 retrospective cohorts.[10]
Who actually needs potassium monitoring. The Plovanich finding does not apply to: - Women over 45 (a 2026 JAAD retrospective cohort study of females over 45 on spironolactone for dermatologic conditions did find a higher hyperkalemia incidence).[11] - Women with kidney disease (CKD stage 3 or worse) — kidneys are how potassium leaves the body. - Women on ACE inhibitors, ARBs, or NSAIDs concurrently — these drugs raise potassium too. - Women supplementing potassium (including high-potassium electrolyte mixes — read the label). - Women with Addison’s disease, untreated adrenal insufficiency, or severe heart failure.
For everyone else: a baseline potassium check is reasonable, and routine 6- or 12-month checks are usually unnecessary unless your prescribing clinician thinks otherwise.
SAFA on safety. The SAFA trial actively tracked side effects across 410 women on 50-100 mg/day. The headline finding: spironolactone was well tolerated. Two side effects were modestly more common than placebo — headache (20% vs 12%) and lightheadedness (19% vs 12%) — and these are almost entirely the diuretic effect (mild dehydration plus a slight blood-pressure drop). The fix is hydration and avoiding the dose at bedtime.[4]
7. Side effects — what’s common, what’s rare, what’s exaggerated
Ordered by real-world frequency. Most are dose-dependent (smaller at 50 mg/day, bigger at 200 mg/day) and most improve after the first 4-6 weeks as your body adapts.
- Increased urination — universal, mild, expected. It’s a diuretic. Drink water. Don’t dose at bedtime.
- Lightheadedness on standing up — common in the first month, especially in women with naturally lower blood pressure. Stand up slowly; salt your food normally; hydrate.
- Breast tenderness or mild breast enlargement — 5-15% on 100 mg/day, more at 200 mg/day. Usually resolves within 2-3 months. If it persists or progresses, dose reduction or switching to a more selective anti-androgen (e.g., bicalutamide) is the next step.
- Menstrual changes — irregular bleeding, spotting, or shortened cycles. This is the main reason clinicians often pair spiro with an oral contraceptive (see section 8).
- Headache — ~20% vs 12% placebo in SAFA. Usually transient.[4]
- Fatigue — small minority, dose-dependent.
- Lowered libido / vaginal dryness — some women, dose-dependent. Often improves with dose adjustment.
Rare but real: - Clinically significant hyperkalemia (>5.5 mmol/L) — <1% in healthy women under 45.[9] - Severe rash / allergic reaction — rare, stop the drug. - Significant gynecomastia (in men, not women) — relevant only if a male family member is borrowing your medication, which they should not be.
Exaggerated fears: - “Spironolactone causes tumors.” Based on a 1980s rat study using doses 25-100× human equivalent. Decades of human data show no increased breast or ovarian cancer risk. The drug actually has a long-standing FDA boxed warning that was reviewed in 2024 and remains a labeling formality, not a clinical concern at PCOS doses.[12] - “Spironolactone causes infertility.” It does not. It is an anti-androgen, not an ovulation suppressor. Fertility returns to baseline within weeks of stopping. The contraception requirement is purely about fetal safety during treatment (see next section).
For a deeper unpacking of side effects, see Aspect’s spironolactone side effects in women guide.
8. Why your doctor will probably require birth control (and when they shouldn’t)
This is the most common cause of patient pushback at the prescription window, and it deserves a clean explanation.
The reason. Spironolactone crosses the placenta. In male fetuses, it can interfere with the development of external genitalia by blocking the same androgen receptors it blocks in your skin and follicles. Case reports of in-utero exposure have documented feminizing effects on male fetuses; a 2024 case report in Frontiers in Pharmacology describes a pregnancy accidentally exposed in mid-gestation.[13] The risk is real, well-characterized, and the reason most prescribing protocols require effective contraception.
What “effective contraception” means here. Hormonal contraceptives (combined pill, ring, patch, hormonal IUD, implant) — yes. Copper IUD — yes. Tubal ligation — yes. Condoms alone — most clinicians want a second method. Natural family planning alone — most clinicians will decline to prescribe.
The synergy bonus. A combined oral contraceptive (COC) also independently suppresses ovarian androgen production. So the spiro + COC combination treats hirsutism and acne faster than either alone, with the combined-OC-plus-spironolactone-vs-metformin comparison generally favoring the spiro/COC arm for hirsutism endpoints.[14] Many women with PCOS are already on a COC for cycle regulation, in which case nothing changes.
When you can take spironolactone without hormonal contraception. - You’re post-menopausal. - You’ve had a permanent contraception procedure (tubal ligation, salpingectomy, hysterectomy). - You have a copper IUD or other reliable non-hormonal method and have agreed to the protocol with your clinician. - You’re not in a relationship that includes pregnancy-possible sex (some clinicians accept this; many do not).
If you’re trying to conceive, spironolactone is stopped at least 1 month before active try-to-conceive cycles begin. The drug is short half-life (~1-2 days); androgens return to baseline within weeks.
9. Spironolactone vs metformin vs GLP-1 — what fixes what
The 2026 reader is often already on (or considering) a GLP-1 agonist like semaglutide or tirzepatide for insulin/weight. Here’s a clean comparison of the three most-relevant PCOS medications, by what they actually do:
| Spironolactone | Metformin | GLP-1 agonist (e.g., semaglutide) | |
|---|---|---|---|
| Mechanism | Blocks androgen receptors; modestly lowers androgen synthesis | Reduces hepatic glucose output; improves insulin sensitivity | Slows gastric emptying; central appetite reduction; improves insulin sensitivity |
| Best for | Hirsutism, acne, scalp thinning | Insulin resistance, metabolic, mild weight, ovulation | Significant weight loss, severe metabolic, insulin resistance |
| Weight effect | Neutral | Mild loss (1-3 kg in trials) | Substantial loss (10-20% in trials) |
| Hirsutism effect | Strong | Modest | Modest (indirect via insulin) |
| Acne effect | Strong (SAFA RCT) | Mild | Mild (indirect) |
| Ovulation/fertility | No direct effect | Modest improvement | Modest improvement; stop 2 months pre-conception |
| Onset of visible result | 3-6 months | 1-3 months (metabolic); 3-6 months (skin) | 4-8 weeks (appetite, weight) |
| Pregnancy | Stop before conception (teratogenic to male fetus) | Generally continued through pregnancy if needed | Stop ≥2 months before conception |
| Cost (US, 2026 generic) | $5-15/month | $5-15/month | $1,000+/month if uncovered |
The drugs are complementary, not competitive. Many women with insulin-resistant PCOS run on metformin or a GLP-1 for the metabolic engine and add spironolactone for residual hirsutism/acne. The Endocrine Society 2008 hirsutism guideline and the 2023 international PCOS guideline both endorse this combination approach where indicated.[6][15] Aspect’s metformin for PCOS deep-dive covers the engine-side decision in detail.
10. Expert perspective
Dr. Lubna Pal, MBBS, MS — Director of the Yale Polycystic Ovary Syndrome Program at Yale School of Medicine; past board chair of Androgen Excess and PCOS Society. Dr. Pal’s published work and clinical commentary emphasize that PCOS treatment is symptom-led, not protocol-led: that the four-subtype framework matters because starting the wrong drug delays results and erodes trust. Her position on spironolactone is that it’s appropriate as a long-term add-on for women whose primary complaint is androgen-driven (hirsutism, acne, scalp thinning), and that pairing it with metabolic-engine treatment (insulin sensitization) produces the most complete result.
— See her Yale faculty profile and published commentary for primary-source positioning.
Dr. Sara Gottfried, MD — Harvard-trained gynecologist and integrative medicine physician; author of The Hormone Cure and Brain Body Diet; Director of Precision Medicine at the Marcus Institute of Integrative Health, Thomas Jefferson University. Dr. Gottfried’s framework — paraphrased from her published books and clinical lectures — emphasizes the upstream causes of androgen excess (stress, insulin, gut, sleep) and uses spironolactone strategically: as a bridge while upstream work is happening, or as a long-term tool when lifestyle alone doesn’t close the gap. Her caution is that drug-only protocols often hit a ceiling without addressing the cortisol-insulin-androgen axis.
— See saragottfriedmd.com and her published books for primary-source commentary.
(Each expert quote block renders in the Webflow template as: circular headshot placeholder, bold name, 1-line credential, the paraphrased position, source link. Never fabricate direct quotes — paraphrase published positions with attribution and link out.)
11. Where Aspect Health fits in (the CGM-and-coaching angle)
If you’re reading this and trying to decide whether spironolactone is the right next move, the most useful thing to know is this: in our coaching cohort, the women who do best on spironolactone are the ones who already know what their PCOS subtype is, and what the engine underneath their symptoms is.
That’s where a continuous glucose monitor (CGM) changes the conversation. Two weeks of CGM data tells you, quantitatively, whether insulin resistance is the dominant driver — your fasting glucose, your post-meal spikes, your overnight stability. If your CGM looks insulin-typical (40+ point spikes after rice, prolonged hyperglycemia after dinner), the case for metformin or a GLP-1 before spironolactone gets stronger. If your CGM is clean — flat lines, controlled spikes, no signs of insulin chaos — you’re more likely in the adrenal or post-pill PCOS bucket where spironolactone is a sensible first-line.
The Aspect PCOS Protocol pairs that CGM data with a registered dietitian and a women’s-health coach who’s seen this play out across hundreds of cases. The point isn’t to replace your prescriber — it’s to give them (and you) the data to choose the right drug, in the right order, instead of trial-and-error across two years and three specialists.
Find out if spironolactone fits your PCOS subtype
The Aspect quiz maps your symptoms + labs against the 4-PCOS-types framework in 3 minutes — so you'll know whether spironolactone, metformin, or both belong in your plan.
Find my PCOS type →12. FAQ
Does spironolactone work for facial hair? Yes. The best-studied use of spironolactone in women with PCOS is hirsutism — unwanted coarse hair on the face, chin, upper lip, chest, abdomen, or back. Most women on 100-200 mg/day see a measurable reduction in hair density and growth rate by month 6, with maximum benefit around month 12. It doesn’t remove existing terminal hairs (those require laser or electrolysis), but it stops new ones being recruited.
How long does spironolactone take to work for PCOS? Hormonal acne starts improving around month 3. Hirsutism improvement becomes visible around month 6 and reaches its peak at month 12. Scalp hair takes the longest — 12+ months of consistent dosing is typical for measurable regrowth. Most clinicians review the response at 6 and 12 months.
What is the maximum dose of spironolactone for PCOS? For PCOS use, 100-200 mg/day is the standard effective range. The licensed maximum (originally for heart failure) is 400 mg/day, but this is rarely used at the PCOS indication. Doses above 200 mg/day for cosmetic indications are usually reserved for very severe hirsutism, and only after lower-dose trials have plateaued.
Will I gain weight on spironolactone? No. Spironolactone is weight-neutral. It is a mild diuretic, so very early in treatment you may lose 1-2 pounds of water weight. After that, weight tracks your diet, training, and metabolic state — not the drug.
Can I take spironolactone without birth control? Most clinicians will require effective contraception if you can become pregnant, because spironolactone is teratogenic to a male fetus’s external genital development. The exceptions are women who are post-menopausal, have had a permanent contraception procedure, or are using a reliable non-hormonal method (e.g., copper IUD) with their clinician’s sign-off.
Can I get pregnant after stopping spironolactone? Yes. Spironolactone has a short half-life (~1-2 days) and androgens return to baseline within weeks of stopping. Plan to stop at least 1 month before active try-to-conceive cycles. The drug does not impair long-term fertility.
What happens if I stop spironolactone? Androgens return to your pre-treatment baseline within 3-6 months. Hirsutism, acne, and scalp thinning gradually return to where they were if the underlying driver hasn’t been addressed. This is why most women stay on spironolactone long-term if it’s working and well-tolerated.
Does spironolactone help with PCOS weight loss? Not directly. Spironolactone is weight-neutral. If insulin resistance is driving both your symptoms and your weight, the medication that helps weight is metformin, a GLP-1 agonist, or — most often — lifestyle change (see Aspect’s PCOS weight-loss approach).
Spironolactone vs metformin — which should I try first? It depends on your PCOS subtype. If your primary problem is androgen-driven (hirsutism, acne, scalp thinning) and insulin is not the engine, spironolactone is the better first move. If your primary problem is metabolic — insulin resistance, weight, irregular ovulation — metformin (or a GLP-1) addresses the engine and may also reduce androgens enough on its own. Many women end up on both. See the comparison table in section 9.
13. Bottom line
Spironolactone is one of the cleanest, most evidence-supported, and most affordable medications available for the androgen symptoms of PCOS. The 2026 picture — anchored by the SAFA acne trial, recent hirsutism meta-analyses, and modernized hyperkalemia data — is that for the right patient, at the right dose, with the right concurrent contraception, this is a low-risk, high-yield tool.
The right patient, in 2026, is increasingly someone who has already named her PCOS subtype, addressed the engine of her symptoms (insulin or adrenal or inflammatory), and is using spironolactone as the targeted skin-and-hair lever rather than as a first-line guess. That’s a meaningfully different conversation than the one happening in most 7-minute appointment slots — and it’s the conversation Aspect’s PCOS Protocol is built around.
.avif)
